Altered expression of signaling genes in Jurkat cells upon FTY720 induced apoptosis
Fang Wang1, Wenfeng Tan, Dunming Guo
1The Lab of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China;
Abstract:
FTY720, a novel immunosuppressant, has a marked activity in decreasing peripheral blood T lymphocytes upon oral administration. Recent investigations suggest that the action of FTY720 on lymphocytes may result from its ability to induce cell apoptosis. However, the cell signaling mechanism involved in the FTY720-induced cell apoptosis remains unclear. Here we examined the apoptotic signal pathways mediated by FTY720 in Jurkat cells using microarray analysis. The results showed that FTY720 can induce Jurkat cell apoptosis in a dose and time dependent manner as assessed by cell viability, Hoechst 33258 staining, Annexin V binding and DNA fragmentation tests. cDNA microarray analysis showed that 10 μM of FTY720 up-regulated 54 and down-regulated 10 genes in Jurkat cells among the 458 apoptotic genes examined following the 6 h incubation period. At least five-fold increased expression of modulator of apoptosis-1 (MOAP-1), vascular endothelial growth factor (VEGF), tumor necrosis factor receptor-associated factors (TRAF 6), Caspase 2 (CASP 2), E2F transcription factor 1 (E2F 1) and Casapse 5 (CASP 5) genes was observed in microarray analyses; these results were confirmed with reverse transcription polymerase chain reaction (RT-PCR) examination. Our findings suggest that the mitochondria related signaling pathways are the key pathways involved in the FTY720-induced apoptosis in Jurkat cells. And our results provide a new insight into the mechanism of FTY720, which allows us to draw the first simple diagram showing the potential pathways mediated by FTY720.
Insights
FTY720, an immunosuppressant, induces Jurkat cell apoptosis via mitochondrial signaling pathways. This study identifies key genes like MOAP-1 and VEGF involved in FTY720
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- FTY720 is a novel immunosuppressant affecting T lymphocytes.
- FTY720's mechanism for inducing lymphocyte apoptosis is not fully understood.
- Investigating apoptotic signaling pathways is crucial for understanding FTY720's action.
Purpose of the Study:
- To elucidate the cell signaling mechanisms of FTY720-induced apoptosis in Jurkat cells.
- To identify specific genes and pathways modulated by FTY720.
- To provide a mechanistic insight into FTY720's immunosuppressive effects.
Main Methods:
- Jurkat cells were treated with FTY720.
- Apoptosis was assessed using cell viability, Hoechst staining, Annexin V binding, and DNA fragmentation assays.
- cDNA microarray analysis and reverse transcription polymerase chain reaction (RT-PCR) were employed to examine gene expression.
Main Results:
- FTY720 induced Jurkat cell apoptosis in a dose- and time-dependent manner.
- Microarray analysis revealed significant up-regulation of 54 genes and down-regulation of 10 genes related to apoptosis.
- Key genes such as MOAP-1, VEGF, TRAF 6, CASP 2, E2F 1, and CASP 5 showed increased expression.
Conclusions:
- Mitochondria-related signaling pathways are central to FTY720-induced apoptosis in Jurkat cells.
- The study provides novel insights into the molecular mechanisms of FTY720.
- A potential signaling pathway diagram for FTY720-mediated apoptosis was proposed.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The JAK-STAT Signaling Pathway


